相关实验视频

Updated: Jun 27, 2025

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants

Published on: May 4, 2018

最近的趋势和克服 Pseudomonas aeruginosa 感染的挑战

Alessandra Ammazzalorso¹, Arianna Granese², Barbara De Filippis¹

¹Department of Pharmacy, G. d'Annunzio University, Chieti, Italy.

Expert opinion on therapeutic patents

|April 29, 2024

概括

新的专利分子显示出对抗多药耐药性Pseudomonas aeruginosa (PA) 感染的前景. 这些新型化合物,包括和抗体,针对创新的途径来克服PA中的抗生素耐药性.

科学领域:

细菌学细菌学是一门学科.
药理学药理学是指药理学的学科.
专利法专利法专利法

背景情况:

伪菌 (Pseudomonas aeruginosa,简称PA) 是一种格拉姆阴性细菌,会引起严重的感染,特别是在免疫受损的个体中.
治疗PA感染的一个主要挑战是其快速发展的多药性耐药性.
迫切需要新的治疗策略来改善患者的治疗结果.

研究的目的:

审查和总结最近的专利文献 (2020-2023) 针对针对Pseudomonas aeruginosa抗生素耐药性的新分子.
为了确定创新的治疗点和结构新的化合物用于PA治疗.

主要方法:

进行了广泛搜索的专利文件,声称新的PA抑制剂.
选择和总结的分子与报告在体外和体内活性对PA物种.
根据探索的抗生素耐药性目标对发现进行了分类.

主要成果:

识别了结构新型化合物,与现有抗生素不同,具有中高分子量和异环环.
突出和抗体作为新兴的替代治疗选择.
探索了涉及PA抗生素耐药性的各种创新目标.

结论:

最近的专利文献揭示了有希望的新化学实体和生物物质,用于对抗多药耐药PA.
这些新的方法提供了超越传统抗生素的扩大治疗可能性.
继续在这一领域的研究和开发对于应对PA感染日益增长的威胁至关重要.

关键词:

伪omonas aeruginosa 这种类型的病毒.抗生素耐药性抗生素耐药性抗微生物药物是一种抗菌药物.格拉姆阴性细菌是一种细菌.抑制剂抑制剂抑制剂多重耐药性 (MDR) 是一种多重耐药性.阻力机制的阻力机制

更多相关视频

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

相关概念视频

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...